FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
Americans may finally be able to self-administer a flu vaccine at home, with the FDA approving the nasal spray FluMist for ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.